VIDA Insights
VIDA Insights is a comprehensive lung intelligence solution, empowering providers with quantitative data and impactful visualizations.

- CT
- Pulmonary
- Thoracic
Empowering Providers with Lung Intelligence
VIDA Insights automatic analysis is an Al-powered analysis of an inspiratory chest CT scan, providing a flag of lung density abnormalities that may be indicative of emphysema (COPD) or interstitial lung abnormalities (IL As).

~29% improved nodule detection
American Journal of Roentgenology. 2018;210: 480-488. 10.2214/AJR.17.18718

26% faster nodule search time
American Journal of Roentgenology. 2018;210: 480-488. 10.2214/AJR.17.18718

Reduce interoperator variability with ClearRead CT Detect
Manual nodule detection is a task associated with interoperator variability. With ClearRead CT Detect, interreaderagreement is improved.
1. Nam liber tempor cum soluta nobis eleifend option congue nihil imperdiet doming
2. Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Magna aliquam erat volutpat tempo molestie vesse
1. Nam liber tempor cum soluta nobis eleifend option congue nihil imperdiet doming
2. Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Magna aliquam erat volutpat tempo molestie vesse
Topographic MPR (tMPR)
The tMPR is a patented technique to quickly review the majority of airways (80-95%) in a patient in three images: 1) coronal, 2) sagittal right, and 3) sagittal left, all without compromising context and resolution. Unlike traditional curved multiplanar reformations (MPR) and minimum intensity projections (MinlP), tMPR maximizes the number of airways in a single view while maintaining orientation, branching complexity and resolution. Traditional rendering techniques cannot offer all these features in a single view.
Lung Density & tMPR - Density & Volumetric Analysis
Density & Volumetric Analysis There are three density bands displayed (low, normal, and high) that visually demonstrate the density distribution along with providing a quantified density analysis. % Low Density defined as ≤-950 HUas a surrogate for emphysema, flagged when ≥ 5%.% Normal Density defined as between >-950 HU and <-700 HU as a surrogate for normal lung tissue that is unremarkable.% High Density defined as -700 HU to -250 HU as a surrogate for interstitial lung abnormalities (e.g., ground glass opacities, reticulations), flagged when ≥ 10%.These visuals show the density percentages for each lung region along with color coding for the low and high densities. Low- and high density percentages will only appear if the percentage is above the physiologically significant threshold as indicated above. The percentages of normal lung density will always be displayed. The coloring used to flag physiologically significant low- or high-density uses a continuous gradient, meaning that as the low- or high density % increases, the coloring displayed will gradually get darker showing relative difference quickly and over time.
Texture & Subpleura Views
The texture analysis section is automatically generated when Insights has flagged areas of High Density in either the lung or lobe at the clinically significant threshold (≥10% High Density) relating to interstitial lung abnormalities. This section will be suppressed when the High Density does not meet this threshold, when contrast media is present, or in the instance of an algorithm failure. Texture includes the features of Ground Glass/Reticulations, Consolidation and Honeycombing. These features are classified and quantified by percentage and liters of total area affected. A lung schematic is provided to assess distribution of texture in each lung, lobe and core/peel region including peripheral, central, or diffuse (central and peripheral).
Automatic Analysis
VIDA Insights automatic analysis is an Al-powered analysis of an inspiratory chest CT scan, providing a quick flag of lung density abnormalities that may be indicative of emphysema (COPD) or interstitial lung abnormalities (IL As). The analysis includes enhanced airway visualizations (topographic MPRs (tMPR)) to increase the quality, precision, and efficiency in reviewing and analyzing respiratory CT abnormalities.
References
- Cosgrove et al, Barriers to timely diagnosis interstitial lung disease, BMC Pulmonary Medicine, 2018
- FDA Summary K200990
- LL-60010 VIDA Insights IFU platforms V3.3 September 2021
- https://blog.vidalung.ai/osf-healthcare-partnership
What Customers Are Saying
The insights provided by their [VIDA Insights] solutions will empower our team to streamline care coordination for all patients with or at-risk of developing respiratory conditions.
Matthew Kuhn
MD, Radiologist at UnityPoint Health
May not reflect a typical user experience; actual results may vary.
What Customers Are Saying
The breadth and complexity of lung diseases demand innovation for both diagnostic and therapeutic workflows. VIDA's enterprise wide lung intelligence solution will empower our teams to deliver more precise, personalized care to our respiratory patients.
Kevin Fahey
MD, Cardiothoracic Radiologist at OSF Healthcare
May not reflect a typical user experience; actual results may vary.
